Oscar Health, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $2.9 Billion | 7/10 | UNH $481.8B |
CVS $83.0B |
CI $81.3B |
HUM $30.6B |
CNC $28.7B |
MOH $15.1B |
OSCR $2.9B |
ALHC $2.6B |
CLOV $2.2B |
BHG $130.5M |
Gross Margin | 100% | 1/10 | OSCR 100% |
MOH 100% |
HUM 89% |
CI 85% |
CLOV 83% |
UNH 21% |
CNC 20% |
ALHC 11% |
BHG -13% |
CVS -55% |
Profit Margin | -6% | 9/10 | UNH 5% |
HUM 2% |
MOH 2% |
CNC 1% |
CVS 0% |
CI 0% |
CLOV -3% |
ALHC -4% |
OSCR -6% |
BHG -83% |
EBITDA margin | -6% | 9/10 | UNH 5% |
CI 4% |
MOH 4% |
HUM 3% |
CVS 1% |
CNC 0% |
ALHC -2% |
CLOV -3% |
OSCR -6% |
BHG -77% |
Quarterly Revenue | $2.4 Billion | 7/10 | UNH $100.8B |
CVS $95.4B |
CI $63.7B |
CNC $40.8B |
HUM $29.4B |
MOH $10.5B |
OSCR $2.4B |
ALHC $692.4M |
CLOV $331.0M |
BHG $292.9M |
Quarterly Earnings | -$153.5 Million | 9/10 | UNH $5.5B |
HUM $480.0M |
CNC $283.0M |
MOH $251.0M |
CVS $87.0M |
CI $86.0M |
CLOV -$9.2M |
ALHC -$26.4M |
OSCR -$153.5M |
BHG -$242.3M |
Quarterly Free Cash Flow | $0 Million | 7/10 | HUM $1.7B |
CLOV $58.4M |
ALHC $16.9M |
CI -$353.0M |
BHG -$436.9M |
CVS -$1.4B |
OSCR -$0 |
UNH -$0 |
CNC -$0 |
MOH -$0 |
Trailing 4 Quarters Revenue | $9.2 Billion | 7/10 | UNH $401.3B |
CVS $369.0B |
CI $232.5B |
CNC $163.1B |
HUM $115.0B |
MOH $40.7B |
OSCR $9.2B |
ALHC $2.5B |
BHG $1.6B |
CLOV $1.5B |
Trailing 4 Quarters Earnings | $25.4 Million | 7/10 | UNH $100.8B |
CVS $95.4B |
CI $63.7B |
CNC $40.8B |
HUM $29.4B |
MOH $10.5B |
OSCR $2.4B |
ALHC $692.4M |
CLOV $331.0M |
BHG $292.9M |
Quarterly Earnings Growth | -2% | 7/10 | CNC 529% |
CI 110% |
CLOV 78% |
ALHC 25% |
MOH 16% |
UNH 2% |
OSCR -2% |
BHG -29% |
HUM -42% |
CVS -96% |
Annual Earnings Growth | 107% | 2/10 | CNC 128% |
OSCR 107% |
CLOV 84% |
MOH 24% |
BHG 5% |
UNH -3% |
ALHC -20% |
CVS -37% |
CI -38% |
HUM -63% |
Quarterly Revenue Growth | 67% | 1/10 | OSCR 67% |
ALHC 52% |
CI 30% |
MOH 16% |
HUM 11% |
UNH 7% |
CVS 6% |
CNC 3% |
CLOV -31% |
BHG -47% |
Annual Revenue Growth | 60% | 1/10 | OSCR 60% |
ALHC 34% |
CI 19% |
MOH 17% |
UNH 8% |
HUM 8% |
CNC 6% |
CVS 3% |
CLOV -24% |
BHG -70% |
Cash On Hand | $1.5 Billion | 7/10 | UNH $29.1B |
CNC $14.1B |
CVS $6.9B |
CI $5.9B |
HUM $5.1B |
MOH $4.7B |
OSCR $1.5B |
ALHC $340.3M |
BHG $87.3M |
CLOV -$0 |
Short Term Debt | $0 | 9/10 | UNH $4.5B |
CI $2.6B |
HUM $1.1B |
CVS $800.0M |
BHG $303.9M |
CNC $110.0M |
ALHC $1.6M |
CLOV $1.3M |
OSCR -$0 |
MOH -$0 |
Long Term Debt | $299.6 Million | 6/10 | CVS $75.1B |
CI $30.2B |
CNC $18.4B |
HUM $11.9B |
MOH $3.1B |
OSCR $299.6M |
ALHC $210.4M |
BHG $66.4M |
CLOV $2.3M |
UNH $0 |
PE | 112.07 | 1/10 | OSCR 112.07 |
CI 29.81 |
HUM 22.49 |
UNH 21.65 |
CVS 16.55 |
MOH 12.82 |
CNC 8.69 |
ALHC -1.00 |
CLOV -1.00 |
BHG -1.00 |
PS | 0.31 | 6/10 | CLOV 1.45 |
UNH 1.20 |
ALHC 1.06 |
MOH 0.37 |
CI 0.35 |
OSCR 0.31 |
HUM 0.27 |
CVS 0.22 |
CNC 0.18 |
BHG 0.08 |
PB | 2.80 | 3/10 | ALHC 22.68 |
MOH 3.36 |
OSCR 2.80 |
CI 1.92 |
HUM 1.73 |
UNH 1.62 |
CVS 1.11 |
CNC 1.08 |
CLOV 0.00 |
BHG 0.00 |
PC | 1.87 | 8/10 | UNH 16.55 |
CI 13.81 |
CVS 12.07 |
ALHC 7.71 |
HUM 5.97 |
MOH 3.24 |
CNC 2.04 |
OSCR 1.87 |
BHG 1.49 |
CLOV -1.00 |
Liabilities to Equity | 3.77 | 2/10 | ALHC 5.03 |
OSCR 3.77 |
CI 2.74 |
MOH 2.48 |
CVS 2.37 |
CNC 2.12 |
HUM 1.84 |
CLOV 0.91 |
UNH 0.00 |
BHG 0.00 |
ROA | 0.01 | 7/10 | MOH 8% | UNH 7% | CNC 4% | HUM 3% | CVS 2% | CI 2% | OSCR 1% | ALHC -21% | BHG -88% | CLOV -100% |
ROE | 0.03 | 7/10 | BHG 86% |
MOH 26% |
CNC 13% |
HUM 8% |
CVS 7% |
CI 6% |
OSCR 3% |
CLOV -6% |
UNH -100% |
ALHC -126% |
Current Ratio | 1.27 | 6/10 | HUM 1.54 |
CNC 1.47 |
CVS 1.42 |
MOH 1.40 |
CI 1.37 |
OSCR 1.27 |
ALHC 1.20 |
BHG 0.83 |
CLOV 0.00 |
UNH -1.00 |
Quick Ratio | 0.56 | 3/10 | OSCR 112.07 |
CI 29.81 |
HUM 22.49 |
UNH 21.65 |
CVS 16.55 |
MOH 12.82 |
CNC 8.69 |
ALHC -1.00 |
CLOV -1.00 |
BHG -1.00 |
Long Term Debt to Equity | 0.30 | 7/10 | ALHC} 1.84 |
CVS} 1.00 |
CI} 0.72 |
CNC} 0.70 |
MOH} 0.69 |
HUM} 0.68 |
OSCR} 0.30 |
CLOV} 0.01 |
BHG} -0.05 |
UNH} -1.00 |
Debt to Equity | 0.30 | 7/10 | ALHC 1.85 |
CVS 1.01 |
CI 0.78 |
HUM 0.74 |
CNC 0.70 |
MOH 0.69 |
OSCR 0.30 |
CLOV 0.01 |
BHG -0.29 |
UNH -1.00 |
Burn Rate | 9.23 | 4/10 | CNC 29.21 |
HUM 18.31 |
ALHC 9.66 |
OSCR 9.23 |
CI 3.33 |
CVS 2.21 |
BHG 0.27 |
CLOV 0.00 |
UNH -6.61 |
MOH -36.92 |
Cash to Cap | 0.54 | 2/10 | BHG 0.67 |
OSCR 0.54 |
CNC 0.49 |
MOH 0.31 |
HUM 0.17 |
ALHC 0.13 |
CVS 0.08 |
CI 0.07 |
UNH 0.06 |
CLOV 0.00 |
CCR | 7/10 | HUM 3.60 |
BHG 1.80 |
ALHC -0.64 |
CI -4.10 |
CLOV -6.38 |
CVS -16.26 |
OSCR |
UNH |
CNC |
MOH |
|
EV to EBITDA | -11.70 | 8/10 | CNC} 189.58 |
CVS} 182.70 |
UNH} 99.96 |
CI} 42.01 |
HUM} 37.94 |
MOH} 31.70 |
BHG} -1.83 |
OSCR} -11.70 |
ALHC} -211.11 |
CLOV} -265.05 |
EV to Revenue | 0.18 | 10/10 | CLOV 1.45 |
UNH 1.14 |
ALHC 1.01 |
CI 0.47 |
CVS 0.41 |
HUM 0.33 |
MOH 0.33 |
BHG 0.26 |
CNC 0.20 |
OSCR 0.18 |